中国医药2025,Vol.20Issue(1) :90-94.DOI:10.3760/j.issn.1673-4777.2025.01.018

TET甲基胞嘧啶双加氧化酶2和DNA甲基化转移酶3A基因表达水平与骨髓增生异常综合征分型及预后的关系

Relationship between the expression levels of TET methylcytosine dioxygenase 2 and DNA methyltrans-ferase 3A and the classification and prognosis of myelodysplastic syndromes

李素欣 王友君 冯丽倩 王苗 李栋梁 安乐 文文
中国医药2025,Vol.20Issue(1) :90-94.DOI:10.3760/j.issn.1673-4777.2025.01.018

TET甲基胞嘧啶双加氧化酶2和DNA甲基化转移酶3A基因表达水平与骨髓增生异常综合征分型及预后的关系

Relationship between the expression levels of TET methylcytosine dioxygenase 2 and DNA methyltrans-ferase 3A and the classification and prognosis of myelodysplastic syndromes

李素欣 1王友君 1冯丽倩 1王苗 2李栋梁 1安乐 1文文1
扫码查看

作者信息

  • 1. 河北省石家庄市人民医院血液内科,石家庄 050000
  • 2. 河北省沧州中西医结合医院放化疗四科,沧州 061000
  • 折叠

摘要

目的 探索TET甲基胞嘧啶双加氧化酶2(TET2)、DNA甲基化转移酶3A(DNMT3A)基因表达水平与骨髓增生异常综合征(MDS)患者临床分型及预后的关系.方法 回顾性选取2015年1月至2022年12月河北省石家庄市人民医院收治的97例MDS患者纳入观察组,另选取同期本院体检不合并血液系统疾病者90例纳入对照组、再生障碍贫血患者87例纳入相似对照组.比较3组TET2、DNMT3A基因表达水平,对比MDS各分型以及各预后分级患者基因表达水平差异.结果 观察组TET2基因表达水平均低于对照组和相似对照组,DNMT3A基因表达水平均高于对照组和相似对照组(均P<0.001),但在MDS不同分型患者间比较,差异均无统计学意义(均P>0.05).随着预后危险程度增加,TET2基因表达水平整体呈现降低趋势,DNMT3A基因表达水平整体呈现升高趋势(均P<0.001).TET2基因表达水平与MDS预后不良呈负相关(r=-0.664,P<0.001),DNMT3A基因表达水平与MDS预后不良呈正相关(r=0.639,P<0.001).结论 TET2、DNMT3A基因表达水平在MDS各分型间无明显差异,但与MDS预后显著相关,临床上对于患者预后判断具有参考意义.

Abstract

Objective To explore the relationship between the gene expression levels of TET methylcy-tosine dioxygenase 2(TET2)and DNA methyltransferase 3 A(DNMT3A)and the clinical classification and prognosis of patients with myelodysplastic syndromes(MDS).Methods A total of 97 patients with MDS admitted to Shijiazhuang People's Hospital,Heibei Province from January 2015 to December 2022 were retrospectively selected as the observation group,and 90 people without blood system diseases in the same hospital during the same period of physical examination were selected as the control group,and 87 patients with aplastic anemia were selected as the similar control group.The expression levels of TET2 and DNMT3A genes in the three groups were compared,and the differences of gene expression levels in patients with different MDS types and prognostic grades were compared.Results The expression level of TET2 gene in the observation group was lower than those in the control group and similar control group,and the expression level of DNMT3A gene was higher than those in the control group and similar control group(all P<0.001).However,there was no significant difference between patients with different types of MDS(all P>0.05).With the increase of prognosis risk,the expression level of TET2 gene showed an overall downward trend,and the expression level of DNMT3A gene showed an overall upward trend(all P<0.001).The expression level of TET2 gene was negatively correlated with the poor prognosis of MDS(r=-0.664,P<0.001),and the expression level of DNMT3A gene was positively correlated with the poor prognosis of MDS(r=0.639,P<0.001).Conclusion The expression levels of TET2 and DNMT3A genes are not significantly different among different types of MDS,but are significantly related to the prognosis of MDS,and have reference significance for the prognosis of patients in clinic.

关键词

骨髓增生异常综合征/TET甲基胞嘧啶双加氧化酶2/DNA甲基化转移酶3A/预后

Key words

Myelodysplastic syndrome/TET methylcytosine dioxygenase 2/DNA methyltransferase 3A/Prognosis

引用本文复制引用

出版年

2025
中国医药
中华医学会

中国医药

影响因子:1.356
ISSN:1673-4777
段落导航相关论文